Endurance of erythrocyte series in chemotherapy

Hematopoietic bone marrow toxicity is most often the limiting factor for chemotherapy doses. Increasing the intensity of chemotherapy doses (higher doses or more frequent administration) would improve antitumor effects, but the hematological toxicity does not allow these dose increases. This study e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Exp Ther Med
Main Authors: Săftescu, Sorin, Popovici, Dorel, Oprean, Cristina, Negru, Alina, Croitoru, Adina, Zemba, Mihail, Yasar, Ionela, Preda, Maria, Negru, Șerban
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2020
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604759/
https://ncbi.nlm.nih.gov/pubmed/33149778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9344
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki